What people report
Retatrutide reviews: what people report
Read 98 people, 3 sitesPublished by PepVault
Of the 98 people whose Retatrutide write-ups we read, 71 describe a change they wanted (62 a change in weight or appetite; 6 more energy or strength; 5 better sleep or vivid dreams), 1 noticed nothing and 49 describe something unwanted.
What people report
71 of the 98 people describe at least one change they wanted. Each bar counts the people who named anything in that group, once each, out of all 98; the line under it says what they named, and how many named it. 8 of them took Retatrutide alongside other peptides at the same time.
What went wrong or did nothing
49 of the 98 people describe something they didn’t want, and 1 noticed nothing at all.
Your report
Taken Retatrutide? What did you notice?
One tap to start. About 30 seconds, no account.

When people say it begins
7 of the 98 people say when they first noticed something; 91 don’t.
What people took it for
28 of the 98 people say what they took it for; 70 don’t.
How it’s thought to work
Shown in people
Retatrutide is one molecule that acts on three hormone receptors at once: GLP-1 and GIP, which slow the stomach and quiet hunger, and glucagon, which draws fat out of the liver and, in mice, raised the energy the body burns. In controlled trials in people it lowered body weight and liver fat far more than a dummy shot, and the trials recorded a faster resting heart rate that rose with the dose.
Sources: Jastreboff et al., 2023: weight and heart rate in a phase two trial; Sanyal et al., 2024: liver fat in a phase two trial; Jastreboff et al., 2026: TRIUMPH-1, the phase three trial in obesity
What studies show
Our research section has 16 study pages on Retatrutide: 12 in people, 3 in mice and 1 in mice and hamsters.
The largest trial so far gave 2339 adults with obesity a weekly shot of retatrutide or a dummy shot for 80 weeks (TRIUMPH-1); on the highest dose their weight fell by 25.0% on average, against 3.9% on the dummy shot.
- Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis
- Retatrutide: top odds of 15% or more weight loss across 19 trials
- Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials
- Retatrutide: HbA1c down up to 1.94% in TRANSCEND-T2D-1
- Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1
- Retatrutide: 26.1% fat mass loss at 36 weeks in type 2 diabetes
- Retatrutide: less hunger and overeating vs placebo at higher doses
- Retatrutide: up to 82.4% less liver fat at 24 weeks in MASLD trial
- Retatrutide: 24.2% weight loss at 48 weeks in the 12 mg arm
- Retatrutide: up to 8.96 kg placebo-adjusted weight loss in 12 weeks
- Retatrutide 12 mg: UACR 37.0% lower vs placebo in type 2 diabetes
- Retatrutide lowered ANGPTL3/8 in step with triglycerides and LDL-C
- Retatrutide cut body weight by 31% in obese mice with MASH
- Retatrutide: 24.1% weight loss in MC4R-deficient mice over 21 days
- Retatrutide: 14-fold smaller pancreatic tumors in mice
- Retatrutide eased diet-induced steatohepatitis in female mice
- Retatrutide in the library: how it works, half-life and evidence
- Is Retatrutide legal? FDA, DEA and WADA status
- Retatrutide dose guide
Where the reports run ahead of the studies
Most of what people report here, weight loss, less appetite, a faster resting heart rate and burning or tingling skin, also turned up in the controlled trials in people. Where the reports run ahead: 8 of the 98 people describe less wish to drink or smoke, which has been tested only in rats (PubMed, searched November 19, 2026).
Where the reports come from
98 people on 58 pages across 3 sites, written from August 2024 to November 2026. Read on November 19, 2026.
The largest single site, X, gave 41 of the 98 (42%).
Peptide Critic, which runs its forum, also runs a shop on its own site that sells injection pens and supplies, not peptides.
On the forums we stopped at about sixty people, the limit we set for every compound: these are the open threads with the most first-person reports, not every post that names retatrutide. On X, the search reaches back only a few days for the newest posts.
- rapamycin.news forum, the “Retatrutide” thread: 15 people
- Peptide Critic forum, a thread on coming off retatrutide: 6 people
- Peptide Critic forum, a thread on what retatrutide or tirzepatide changed: 6 people
- rapamycin.news forum, the “Experience with GLP-1s” thread: 6 people
- Peptide Critic forum, a thread on skin sensations: 4 people
- Peptide Critic forum, a thread on switching from retatrutide to tirzepatide: 3 people
- Peptide Critic forum, a thread on switching to tirzepatide: 2 people
- Peptide Critic forum, a weight-loss progress thread: 2 people
- Peptide Critic forum, a thread on retatrutide and loss of pleasure: 2 people
- Peptide Critic forum, a thread on peptides that surprised people: 2 people
- Peptide Critic forum, a thread for people new to retatrutide: 2 people
- Peptide Critic forum, a thread on retatrutide with tirzepatide: 2 people
- Peptide Critic forum, a thread on vials that seemed weaker: 1 person
- Peptide Critic forum, a thread comparing retatrutide with semaglutide and tirzepatide: 1 person
- Peptide Critic forum, a two-month retatrutide update: 1 person
- Peptide Critic forum, a gallbladder thread: 1 person
- Peptide Critic forum, a thread on constipation: 1 person
- X, public posts: 41 people (post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post)
Read and not counted
- A rapamycin.news member who supplies it to clients: Writes of the clients they sell it to and of their results: the seller’s side of the counter, so not counted.
- A Peptide Critic forum staff member’s posts: The same account posts the forum’s vendor sales roundups, and the site runs its own store: the seller’s side of the counter, so not counted.
- Vendor reviews and vial-quality threads on the Peptide Critic forum: Written about a seller or a vial rather than about what the person noticed; an advertisement or a complaint about a product, so not counted.
- Reports about someone else (a husband, a wife, a son, a friend, clients): Second-hand; only a person’s own report counts.
- Posts in the same threads about tirzepatide or semaglutide alone: Counted only where the person names retatrutide among what they took; the others belong to those drugs’ own counts.
- Posts with a plan, a dose question or a source question and no outcome: Most posts in these threads; nothing noticed was said, either way.
- LongeCity forum: Searched: its only retatrutide threads are a vendor’s featured thread and questions about where to buy it, with no member’s own report.
- Posts on X from sellers, about someone else, or with no outcome: Retellings of trial results, guide threads, a vendor, a post about selling to others, posts about a brother, a husband or parents, stacks where the effect could not be put on retatrutide, and questions, plans and dose talk; not counted.
- Reddit: Not part of this count.
How we counted
We read every open write-up we could find by people who took Retatrutide, on its own page, and counted each person once however often they posted, including those who noticed nothing. Sellers, clinics, shop reviews and anyone who earns on a sale are not counted, and neither is a search result’s snippet; the list above names what we read and left out. Write-ups lean positive, because people who notice nothing rarely write about it and expecting an effect can produce one. People on X and on the forums can’t be matched to each other, so someone who wrote in both places may be counted twice.
Spot an error? feedback@pepvault.app. How we research. This page reports what people say; it is not medical advice.